Pharmaceutical Executive-11-01-2014

Features

December 12, 2014

The science of drug discovery is back on script-and the stars are cued up for a new generation of breakthrough therapies. But is pharma ready to raise its game and cut a deal with all those "prove it to me" payers?

Pharmaceutical Executive
Column

November 01, 2014

Agency's plan for reporting clinical trial data has sparked strong reactions from health campaigners, industry, and patients.

Pharmaceutical Executive
Column

November 01, 2014

Insurers, physicians attack high-cost therapies in anticipation of specialty drug surge.

Pharmaceutical Executive

By rethinking the role of the sales rep and the new skills it demands, pharma companies can put themselves in a prime competitive position.

Pharmaceutical Executive

The rush to digital will continue at a fast clip, but marketers need to reacquaint themselves with their brands' audiences.

Pharmaceutical Executive

Treatment Action Group (TAG) reaches a milestone in improving access to much-needed treatments for tuberculosis.

Pharmaceutical Executive
From the Editor

November 01, 2014

Amid a resurgence in drug development for hard-to-treat conditions, the bigger question is whether the times are as good for the industry tasked with rendering basic science into therapeutically effective medicines.

Pharmaceutical Executive
Features

November 01, 2014

Jesper Hoiland, Novo Nordisk's President for North America, assesses the challenges and opportunities during his first year at the helm of the diabetes franchise leader's biggest affiliate market.